Roivant Sciences President Sells $17.2M in Shares Following Option Exercise

summarizeSummary

Roivant Sciences' President and CIO, Mayukh Sukhatme, disposed of $17.2 million worth of common shares through a combination of open market sales and net settlement after exercising options, maintaining a flat share count but realizing significant cash.

check_boxKey Events

• President Disposes of $17.2M in Shares

  Mayukh Sukhatme, President and CIO, disposed of 651,558 shares totaling $17.2 million, comprising an $8.9 million open market sale and an $8.2 million net settlement to cover option exercise costs.

• Cashless Option Exercise

  The disposition was part of a cashless exercise of 651,558 stock options, resulting in no net change to the insider's total share holdings.

• Timing Near 52-Week Highs

  The transaction occurred on February 9, 2026, while the company's stock is trading near its 52-week high, following recent positive clinical trial results.

auto_awesomeAnalysis

This Form 4 filing indicates that Mayukh Sukhatme, President and CIO of Roivant Sciences, engaged in a cashless exercise of stock options. He acquired 651,558 shares and simultaneously disposed of an equivalent number of shares totaling $17.2 million. The disposition included an $8.9 million open market sale and an $8.2 million net settlement to cover the exercise price. This transaction follows recent positive Phase 2 results for brepocitinib and occurs while the stock is trading near its 52-week high. While the net share count for the insider remains unchanged, the substantial value of shares disposed for liquidity and to cover exercise costs represents a significant insider selling event, potentially signaling a move to lock in gains after recent positive developments. This continues a pattern of insider dispositions, as evidenced by recent Form 144 filings.